NewsBenzingaNeedham、RxSightの「買い」判断を維持、目標株価を7ドルに引き下げ Needham、RxSightの「買い」判断を維持、目標株価を7ドルに引き下げ Benzinga 2026.11.04 10:14 (GMT+0) Open on Benzinga Other news HC Wainwright & Co. Maintains Buy on Largo, Lowers Price Target to $0.9 Super Micro's AI Business Is Booming, but One Customer Accounts for Stunning 44% of Sale Scroll Proposes Pivot to Permissioned Privacy-AI Network, Plans to Migrate SCR to Ethereum Mainnet Vishay Precision Group Sees Q4 Sales $84.000M-$91.000M vs $89.160M Est Taboola.com Q3 Adj. EPS $0.14, Inline, Sales $462.300M Miss $467.600M Estimate CL Workshop Group Announces ADS Ratio Change From One ADS Representing Eight Ordinary Shares To One ADS Representing 640 Ordinary Shares, Effective November 6
CL Workshop Group Announces ADS Ratio Change From One ADS Representing Eight Ordinary Shares To One ADS Representing 640 Ordinary Shares, Effective November 6
